FDA Approves New Immunotherapy Combo for mNSCLC ...Middle East

Medscape - News
The agency has approved the combination of tremelimumab (Imjudo) and durvalumab (Imfinzi) for use together with chemotherapy for patients with metastatic non–small cell lung cancer (mNSCLC). FDA Approvals

Hence then, the article about fda approves new immunotherapy combo for mnsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves New Immunotherapy Combo for mNSCLC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Parade - before 11 hour & 25 minute


Latest News